African Pharmaceutical Regulatory Intelligence
TERBINAFINE
144 registrations across 11 African markets— 102 active
Markets with TERBINAFINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Tabisafe Tablet_ Tablet | 🇳🇬Nigeria | AnnyGod Pharmaceutical Company Ltd | active | Oct 2030 |
| Terbinafine Tablets USP 250 mg_ Tablet | 🇳🇬Nigeria | Anyi-Tex Pharmaceuticals Limited | active | Jul 2029 |
| Tydisil Tablet Tablet | 🇳🇬Nigeria | Osworth Nigeria Limited | active | Mar 2028 |
| TERFINA 1% CREME TUBE DE 15G | 🇨🇮Côte d'Ivoire | ZYNOVA | active | Jan 2028 |
| LAMISIL TABLET; ORAL | 🇿🇼Zimbabwe | NOVARTIS PHARMA SERVICES AG | active | Dec 2027 |
| TERBINOL 250MG COMPRIME BOITE DE 14 | 🇨🇮Côte d'Ivoire | DAFRA PHARMA GMBH | active | Aug 2026 |
| TERBINOL 1% CREME TUBE DE 15G | 🇨🇮Côte d'Ivoire | DAFRA PHARMA GMBH | active | Aug 2026 |
| Terbinafine 250 mg Tablets Tablet | 🇳🇬Nigeria | SK Medicines Limited | active | Aug 2026 |
| TEGUMA 1% CREME TUBE DE 15G | 🇨🇮Côte d'Ivoire | COOPER PHARMA | expired | Mar 2025 |
| TEGUMA 250MG COMPRIME BOITE DE 14 | 🇨🇮Côte d'Ivoire | COOPER PHARMA | expired | Oct 2024 |
| TEGUMA 250MG COMPRIME BOITE DE 28 | 🇨🇮Côte d'Ivoire | COOPER PHARMA | expired | Oct 2024 |
| TERBEX 1% CREME BOITE DE 15G | 🇨🇮Côte d'Ivoire | NIYA HEALTHCARE PVT. LTD | expired | Sept 2024 |
| LAMISIL 250MG COMPRIME SECABLE BOITE DE 14 | 🇨🇮Côte d'Ivoire | NOVARTIS COTE D'IVOIRESASU | expired | Sept 2024 |
| LAMISIL 1% CREME TUBE DE 15G | 🇨🇮Côte d'Ivoire | GLAXOSMITHKLINE EXPORT LTD | expired | Sept 2024 |
| TALLIS Comprimé sécable / 250 mg | 🇹🇳Tunisia | OPALIA PHARMA | expired | Jul 2023 |
| LAMISIL 1% SOLUTION FLACON DE 15ML | 🇨🇮Côte d'Ivoire | GLAXOSMITHKLINE EXPORT LTD | expired | Aug 2021 |
| ONIFINE 1% CREME BOITE DE 30G | 🇨🇮Côte d'Ivoire | PHARMACEUTICAL INSTITUTE | expired | Jan 2021 |
| ONIFINE 250MG COMPRIME BOITE DE 28 | 🇨🇮Côte d'Ivoire | PHARMACEUTICAL INSTITUTE | expired | Jan 2021 |
| ONIFINE 1% SOLUTION POUR PULVERISATION CUTANEE FLACON DE 30ML | 🇨🇮Côte d'Ivoire | PHARMACEUTICAL INSTITUTE | expired | Jan 2021 |
| ONIFINE 250MG COMPRIME BOITE DE 14 | 🇨🇮Côte d'Ivoire | PHARMACEUTICAL INSTITUTE | expired | Jan 2021 |
| TERBIGEN-GH 250MG COMPRIME BOITE DE 28 | 🇨🇮Côte d'Ivoire | GENERIC HEALTHCARE PVT. LTD | expired | Jan 2020 |
| TERBIGEN-GH 1% CREME TUBE DE 15G | 🇨🇮Côte d'Ivoire | GENERIC HEALTHCARE PVT. LTD | expired | Jan 2020 |
| TINASIL Comprimé / 250 mg | 🇹🇳Tunisia | BEIT JALA Pharmaceutical Co | expired | May 2017 |
| TINASIL Creme dermique / 1% | 🇹🇳Tunisia | BEIT JALA Pharmaceutical Co | expired | May 2017 |
| LAMIFENE 250MG COMPRIME BOITE DE 14 | 🇨🇮Côte d'Ivoire | LABORATOIRES JAMJOOM PHARMA | expired | Oct 2016 |
| LAMIFENE 1% CREME TUBE DE 15G | 🇨🇮Côte d'Ivoire | LABORATOIRES JAMJOOM PHARMA | expired | Oct 2016 |
| TERCYD Solution pour application cutanée / 1% | 🇹🇳Tunisia | ADWYA | expired | Feb 2016 |
| FUNGBAN 250MG TABLETS TABLETS | 🇲🇼Malawi | — | expired | Jun 2014 |
| ONYCAL Creme dermique / 1% | 🇹🇳Tunisia | PHARMAGHREB | expired | Oct 2011 |
| ONYCAL Spray solution / 1% | 🇹🇳Tunisia | PHARMAGHREB | expired | Oct 2011 |
| TALLIS MONODOSE Solution externe / 1% | 🇹🇳Tunisia | OPALIA PHARMA | expired | May 2011 |
| LAMISIL Comprimé sécable / 250 mg | 🇹🇳Tunisia | TERIAK | expired | Aug 2009 |
| TALLIS Comprimé sécable / 250 mg | 🇹🇳Tunisia | OPALIA PHARMA | expired | Jul 2009 |
| LAMISIL Comprimé sécable / 250 mg | 🇹🇳Tunisia | TERIAK | expired | Apr 2008 |
| MYCOPHIL Comprimé sécable / 250 mg | 🇹🇳Tunisia | GALPHARMA | expired | Feb 2007 |
| MYCOPHIL Creme dermique / 1% | 🇹🇳Tunisia | GALPHARMA | expired | Jan 2007 |
| ONYCAL Comprimé sécable / 250 mg | 🇹🇳Tunisia | PHARMAGHREB | expired | Dec 2006 |
| ONYCAL Comprimé sécable / 250 mg | 🇹🇳Tunisia | PHARMAGHREB | expired | Dec 2006 |
| TALLIS Spray solution / 1% | 🇹🇳Tunisia | OPALIA PHARMA | expired | Dec 2006 |
| TERCYD Comprimé sécable / 250 MG | 🇹🇳Tunisia | ADWYA | expired | Sept 2006 |
| LAMISIL Spray solution / 1% | 🇹🇳Tunisia | NOVARTIS SANTE FAMILIALE S.A.S | expired | Mar 2006 |
| TALLIS Comprimé sécable / 250 mg | 🇹🇳Tunisia | OPALIA PHARMA | expired | Feb 2006 |
| TERBISIL Comprimé sécable / 250 mg | 🇹🇳Tunisia | SIPHAT | expired | Feb 2006 |
| TERBISIL Comprimé sécable / 250 mg | 🇹🇳Tunisia | SIPHAT | expired | Feb 2006 |
| TERBISIL Creme dermique / 1% | 🇹🇳Tunisia | SIPHAT | expired | Feb 2006 |
| TERBISIL Creme dermique / 1% | 🇹🇳Tunisia | SIPHAT | expired | Feb 2006 |
| MYCOPHIL Comprimé sécable / 250 mg | 🇹🇳Tunisia | GALPHARMA | expired | May 2005 |
| TALLIS Creme dermique / 1% | 🇹🇳Tunisia | OPALIA PHARMA | expired | Jun 2004 |
| TERCYD Creme dermique / 1% | 🇹🇳Tunisia | ADWYA | expired | Jun 2004 |
| TERCYD Comprimé sécable / 250 MG | 🇹🇳Tunisia | ADWYA | expired | Dec 2003 |
Showing 50 of 144 registrations. Sign up free to search and export all.
TERBINAFINE in Africa — Regulatory Overview
TERBINAFINE is registered across 11 African markets with 144 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco, Tunisia, Côte d'Ivoire, Senegal and 7 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 144 registrations, 102 (71%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.